CC

Perimeter Solutions, Inc. PRM is entering a phase in which contract structure matters as much as wildfire activity. Multi-year agreements, annual price escalators and a larger services base are making the Fire Safety business less dependent on any single fire season.The company still faces weather-driven quarterly swings. Yet its recent contract wins and broader segment mix point to a more durable earnings profile. Perimeter’s new five-year agreement with the United States Defense Logistics Agency covers fire suppression foam and services, with a maximum contract value of $500 million. The company expects the financial impact to begin late in 2026, ramp in 2027 and reach a steadier run rate from 2028 onward.The CAL FIRE renewal adds another five-year anchor. Pricing under that contract rose to align California with other large retardant customers, while annual escalators reinforce revenue durability. Existing federal coverage is also expected to carry forward into the U.S. Wildland Fire Service, supporting planning visibility across agencies. Perimeter Solutions, SA price-consensus-chart | Perimeter Solutions, SA Quote Management believes Perimeter can keep adjusted EBITDA more resilient across normal and milder fire seasons. The company has said variability between a normalized season and a relatively mild one should be roughly in the mid-teens percentage range.That confidence rests on the full-service air base model and more proactive use of retardants. Federal agencies used an aggressive initial-attack strategy in 2025, and management expects that approach to continue in 2026, which could support demand even when reported acres burned are not especially high. Service revenues in Fire Safety have moved from roughly $30 million a few years ago to $108.3 million in 2025. That represented about 17% of total sales and is largely recognized over time.This mix matters because most of the service base is fixed each year. It can cushion product-volume volatility when wildfire timing is unfavorable, while also monetizing the air base infrastructure that supports Perimeter’s customer relationships. Specialty Products gives Perimeter a second growth engine beyond wildfire-driven demand. The segment includes PDI, Intelligent Manufacturing Solutions and Medical Manufacturing Technologies, which was acquired in January 2026.In the first quarter of 2026, Specialty Produc...

It has been about a month since the last earnings report for Chemours (CC). Shares have lost about 4.5% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Chemours due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers. Chemours reported a net loss of $29 million or 19 cents per share for the first quarter of 2026. This compares unfavorably with the year-ago quarter’s net loss of $5 million or 3 cents per share. Barring one-time items, earnings were 5 cents per share, which topped the Zacks Consensus Estimate of a loss of 5 cents. The company reported first-quarter net sales of $1,381 million, reflecting a 1% increase from the previous-year quarter. However, the figure missed the Zacks Consensus Estimate of $1,402.6 million. Net sales were primarily aided by a 2% increase in price and a 3% favorable currency impact, partly offset by a 4% decrease in volumes. Adjusted EBITDA rose 2% year over year to $169 million for the quarter. The increase was driven by higher pricing, favorable currency and other income, which more than offset higher costs and lower sales volumes in the APM and TT segments. The TT division recorded revenues of $559 million in the first quarter, marking a 6% decrease from the previous year. The figure beat our estimate of $543.3 million. This downside was primarily due to a 7% decline in volumes globally and a 2% decrease in pricing, partly offset by a 3% favorable currency impact. In the TSS segment, revenues saw a 22% year-over-year increase, reaching $568 million in the reported quarter. The figure was almost in line with our estimate of $568.3 million. Net sales growth was mainly driven by an 11% increase in price and a 9% rise in volume, with a 2% currency tailwind. Increased pricing was primarily driven by automotive Freon Refrigerant sales in North America. Volume growth was supported by the continued transition to Opteon Refrigerants as well as automotive Freon Refrigerant sales in North America. Revenues in the APM unit amounted to $243 million, which declined 17% year over year. The figure missed our estimate of $256.5 million. The downside was mainly caused by a 19...

Interested in The Chemours Company? Here are five stocks we like better. Chemours beat first-quarter expectations as strong performance in Thermal & Specialized Solutions and Titanium Technologies offset weakness in Advanced Performance Materials, which was hurt by the Washington Works outage. Balance-sheet repair continued with the sale of nearly all Kuan Yin properties and recent debt refinancing, helping the company pay down near-term obligations and target lower leverage over time. Management kept a constructive outlook, guiding for second-quarter sequential growth across the company and reaffirming full-year sales and EBITDA guidance, even as it lowered free cash flow conversion expectations due to tax impacts. Norwegian Cruise Line Cuts Outlook as Headwinds Build Chemours (NYSE:CC) said it opened 2026 with first-quarter results that were “well above earnings expectations,” driven by strong execution in its Thermal & Specialized Solutions and Titanium Technologies segments, while Advanced Performance Materials continued to recover from an outage at the company’s Washington Works facility. President and Chief Executive Officer Denise Dignam told analysts that the quarter reflected “disciplined execution and strategic focus across the company,” with Thermal & Specialized Solutions, or TSS, delivering a record first quarter and Titanium Technologies, or TT, exceeding earnings expectations despite a challenging market backdrop. → Uber's Annual Product Showcase Reveals It Is Coming for Airbnb and Booking Comparing 3 Cruise Stocks: Which Has the Most Upside in 2026? The company also highlighted progress on its balance sheet, including the sale of nearly all of its Kuan Yin properties ahead of schedule. Dignam said Chemours used available proceeds to pay down a meaningful portion of near-term debt and remains on track to complete the sale of the remaining parcel in 2026, which is expected to provide an additional $60 million of gross proceeds. Dignam said Chemours’ TSS business delivered a record first quarter, with net sales rising 22% from the prior-year period. The gains were largely attributed to higher pricing, stronger volumes and favorable product mix across refrigerant markets. → Wells Fargo’s Comeback Is Real—But Not Risk-Free Nuclear, Pharma & Travel Buybacks: Confident or Cautious Signals? The company cited strength in both Freon and Opteon refriger...

It's been a sad week for The Chemours Company (NYSE:CC), who've watched their investment drop 17% to US$22.41 in the week since the company reported its quarterly result. Things were not great overall, with a surprise (statutory) loss of US$0.19 per share on revenues of US$1.4b, even though the analysts had been expecting a profit. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Following the latest results, Chemours' nine analysts are now forecasting revenues of US$6.02b in 2026. This would be a modest 3.5% improvement in revenue compared to the last 12 months. Earnings are expected to improve, with Chemours forecast to report a statutory profit of US$1.21 per share. Before this earnings report, the analysts had been forecasting revenues of US$6.04b and earnings per share (EPS) of US$1.58 in 2026. The analysts seem to have become more bearish following the latest results. While there were no changes to revenue forecasts, there was a pretty serious reduction to EPS estimates. Check out our latest analysis for Chemours Althoughthe analysts have revised their earnings forecasts for next year, they've also lifted the consensus price target 9.8% to US$24.89, suggesting the revised estimates are not indicative of a weaker long-term future for the business. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Chemours at US$30.00 per share, while the most bearish prices it at US$17.00. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation. Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other...

Image source: The Motley Fool. Wednesday, May 6, 2026 at 8 a.m. ET President and Chief Executive Officer — Denise Dignam Senior Vice President and Chief Financial Officer — Shane Hostetter SVP, Titanium Technologies and Chemical Solutions — Arun Viswanathan Denise Dignam: Thank you, Brandon, and thank you, everyone, for joining us. During today's call, I will begin by discussing highlights from our recent performance before turning it over to Shane, who will provide details around our outlook for the second quarter of 2026 and some commentary on the remainder of the year. Finally, I will provide updates on our meaningful progress against our pathway to drive strategy and current view of our operating environment before taking your questions. We started 2026 with strong results, delivering the first quarter that was well above earnings expectations and showcased the strength of Chemours disciplined execution and strategic focus across the company. Both thermal and specialized solutions and Titanium Technologies delivered standout performances with TSS not only achieving another quarter of double-digit year-over-year growth in up-down refrigerants, but also excelling in quota execution and capturing additional opportunities in on refrigerants through sharp market focus and agile commercial execution. TT also exceeded our earnings expectations, driven by global pricing actions, strong commercial discipline across all regions and customer segments and continued operational focus. In Advanced PerformanceMaterials, the business worked to quickly stabilize operations following the Washington Works outage and the same strength in our Performance Solutions order book, especially in high-value data center and semiconductor markets. Adding to the strong performance and aligning with our efforts to improve our balance sheet, we completed the sale of nearly all of our Kuan Yin properties ahead of schedule and promptly use the available proceeds to pay down a meaningful portion of our near-term debt, further strengthening our balance sheet and enhancing Chemour's financial flexibility as we look ahead. We remain on track to complete the sale of the remaining parcel of the land in 2026, which should provide an incremental $60 million of gross proceeds. This development followed the $700 million refinancing completed in March of our 2027 unsecured notes and a portion of our...

The Chemours Company CC reported a net loss of $29 million or 19 cents per share for the first quarter of 2026. This compares unfavorably with the year-ago quarter’s net loss of $5 million or 3 cents per share. Barring one-time items, earnings were 5 cents per share, which topped the Zacks Consensus Estimate of a loss of 5 cents. The company reported first-quarter net sales of $1,381 million, reflecting a 1% increase from the previous-year quarter. However, the figure missed the Zacks Consensus Estimate of $1,402.6 million. Net sales were primarily aided by a 2% increase in price and a 3% favorable currency impact, partly offset by a 4% decrease in volumes. Adjusted EBITDA rose 2% year over year to $169 million for the quarter. The increase was driven by higher pricing, favorable currency and other income, which more than offset higher costs and lower sales volumes in the Advanced Performance Materials and Titanium Technologies segments. The Chemours Company price-consensus-eps-surprise-chart | The Chemours Company Quote The Titanium Technologies division recorded revenues of $559 million in the first quarter, marking a 6% decrease from the previous year. The figure beat our estimate of $543.3 million. This downside was primarily due to a 7% decline in volumes globally and a 2% decrease in pricing, partly offset by a 3% favorable currency impact. In the Thermal & Specialized Solutions segment, revenues saw a 22% year-over-year increase, reaching $568 million in the reported quarter. The figure was almost in line with our estimate of $568.3 million. Net sales growth was mainly driven by an 11% increase in price and a 9% rise in volume, with a 2% currency tailwind. Increased pricing was primarily driven by automotive Freon Refrigerant sales in North America. Volume growth was supported by the continued transition to Opteon Refrigerants as well as automotive Freon Refrigerant sales in North America. Revenues in the Advanced Performance Materials unit amounted to $243 million, which declined 17% year over year. The figure missed our estimate of $256.5 million. The downside was mainly caused by a 19% decrease in volume and a 1% decline in price, partly offset by a 3% favorable currency impact. The volume decline was primarily due to sales constraints from the Washington Works plant outage in the first quarter and the closure of the Advanced Materials SPS Capstone...

Chemours (CC) shares were down 16% in Wednesday trading after the company reported lower Q1 earnings

WILMINGTON, Del., May 5, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the second quarter of 2026. The dividend will be paid on June 16, 2026, to stockholders of record as of the close of business on May 17, 2026. About The Chemours Company The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700 employees and 28 manufacturing sites and serves approximately 2,400 customers in approximately 110 countries. For more information, visit chemours.com or follow us on LinkedIn. CONTACTS: INVESTORS Brandon Ontjes VP, Head of Strategy & Investor Relations +1.302.773.3300 [email protected] NEWS MEDIA Cassie Olszewski Media Relations & Reputation Leader +1.302.219.7140 [email protected] View original content to download multimedia:https://www.prnewswire.com/news-releases/chemours-announces-second-quarter-dividend-302763517.html

Thermal & Specialized Solutions (TSS) achieved record first-quarter results driven by double-digit growth in Opteon refrigerants and sharp commercial execution in the Freon aftermarket. Titanium Technologies (TT) exceeded earnings expectations through disciplined global pricing actions and cost management, despite lower volumes in non-Western markets. Advanced Performance Materials (APM) faced a $25 million EBITDA headwind due to the Washington Works outage, though management reports a stabilized foundation for future quarters. The company successfully accelerated its balance sheet de-risking by completing the sale of Kuan Yin properties ahead of schedule and refinancing near-term debt. Management attributed margin expansion in TSS to strong pricing realization and improved product mix, partially offset by higher input costs for R-32. Operational reliability is being prioritized through the implementation of the Chemours Business System (CBS), which focuses on lean principles and cost efficiency. Second-quarter consolidated net sales are projected to increase 15% to 20% sequentially, supported by seasonal cooling demand and the resumption of normal APM operations. TSS guidance assumes continued strength in automotive aftermarket and Opteon transitions, though management remains cautious regarding soft residential HVAC demand. TT performance in the second half is expected to benefit from April 1 price increases and potential tailwinds as sulfur-related cost inflation impacts sulfate-based competitors. APM is positioned for significant second-half strength driven by an overall segment order book reaching levels not seen in several years, with particular demand strength in semiconductor and data center markets for Performance Solutions products. Management maintains its full-year guidance but lowered free cash flow conversion expectations to above 20% due to specific tax implications from the Kuan Yin land sale. The Washington Works outage and SPS Capstone line closure created a difficult year-over-year comparison for APM, though these discrete events are now considered resolved. A new long-term chlorine supply contract for the DeLisle site replaces a previously planned on-site facility, securing reliable supply at value-accretive economics starting in 2028. Geopolitical volatility in the Middle East is flagged as a risk to energy markets and supply chains, pot...

For the quarter ended March 2026, Chemours (CC) reported revenue of $1.38 billion, up 1% over the same period last year. EPS came in at $0.05, compared to $0.13 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.4 billion, representing a surprise of -1.54%. The company delivered an EPS surprise of +195.24%, with the consensus EPS estimate being -$0.05. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Chemours performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Other Segment: $11 million compared to the $10.78 million average estimate based on three analysts. The reported number represents a change of 0% year over year. Revenues- Titanium Technologies: $559 million compared to the $544.35 million average estimate based on three analysts. The reported number represents a change of -6.4% year over year. Revenues- Advanced Performance Materials: $243 million versus $257.39 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -17.4% change. Revenues- Thermal & Specialized Solutions: $568 million compared to the $565.65 million average estimate based on three analysts. The reported number represents a change of +21.9% year over year. Adjusted EBITDA- Titanium Technologies: $18 million compared to the $3.21 million average estimate based on three analysts. Adjusted EBITDA- Other Segment: $3 million compared to the $1.18 million average estimate based on three analysts. Adjusted EBITDA- Advanced Performance Materials: $5 million versus the three-analyst average estimate of $3.69 million. Adjusted EBITDA- Thermal & Specialized Solutions: $190 million versus $176.61 million estimated by three analysts on average. View all Key Company Metrics for Chemours here>>> Shares of Chemours have returned +25.4% over the past month versus the Z...

WILMINGTON, Del., May 5, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the first quarter 2026. Key First Quarter 2026 Results & Recent Highlights1 Net Sales of $1.4 billion, slightly up compared to the corresponding prior-year quarter, with TSS reporting record first quarter results, with continued double-digit year-over-year sales growth in Opteon™ Refrigerants Net Loss attributable to Chemours of $29 million, or $0.19 per diluted share, compared with Net Loss attributable to Chemours of $5 million, or $0.03 per diluted share, in the corresponding prior-year quarter Adjusted Net Income2 of $8 million, or $0.05 per diluted share, compared to Adjusted Net Income of $19 million, or $0.13 per diluted share, in the corresponding prior-year quarter Adjusted EBITDA2,3 of $169 million compared to $166 million in the corresponding prior-year quarter Announced a global TiO2 price increase effective April 1, 2026, as a continuation of our December price actions; achieved a sequential TiO2 price increase of 3% in Net Sales Received ~$287 million initial net proceeds from the sale of the Kuan Yin site, positioning the Company to paydown €140 million of outstanding debt "Chemours exceeded overall expectations in the first quarter, achieving strong outcomes from both our TSS and TT businesses, paired with the more recent receipt of cash through the completion of a substantial portion of our Kuan Yin property sales enabling us to reduce our debt," stated Denise Dignam, Chemours President and CEO. "These achievements demonstrate our dedication to our Pathway to Thrive strategy and highlight the importance we place on effective execution. While the wider economic landscape remains uncertain, Chemours continues to drive full-year growth while remaining steadfast in prioritizing flexible commercial and operational strategies to ensure Chemours is able to capitalize on opportunities in our key markets." Total Chemours First quarter 2026 Net Sales were $1.4 billion, an increase of 1% compared to the prior-year quarter. Reported Net Sales were primarily driven by a 2% increase in price and a 3% increase in currency, partially off...

WILMINGTON, Del. (AP) — WILMINGTON, Del. (AP) — Chemours Co. (CC) on Tuesday reported a loss of $29 million in its first quarter. On a per-share basis, the Wilmington, Delaware-based company said it had a loss of 19 cents. Earnings, adjusted for non-recurring costs, were 5 cents per share. The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share. The chemical company posted revenue of $1.38 billion in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $1.4 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CC at https://www.zacks.com/ap/CC